News – Page 1086 – Endpoints News

SIGN UP

With CRO consolidation in full swing, Catalent inks a $950M deal to acquire Cook Pharmica and signals an appetite for ...

8 years ago

Atlas ramps up a new biotech player focused on neurology, with a $30M round to fund the work

8 years ago

Ex-GSK CEO, R&D chief Andrew Witty and Moncef Slaoui are jumping into the biotech VC game

8 years ago

AbbVie and Roche tout a positive PhIII combo study of Venclexta, Rituxan in CLL — ahead of FDA pitch

8 years ago

Avanir vet Keith Katkin takes charge at Urovant; Teva unloads assets while uploading new CEO

8 years ago

Harvard biotech wiz Greg Verdine grabs a $55M A round to build a groundbreaking biotech

8 years ago

Bidding war erupts over Dimension’s gene therapy pipeline as Ultragenyx counters Regenxbio deal

8 years ago

Shares rocket up as Nabriva Therapeutics touts a PhIII win for antibiotic

8 years ago

Cut loose from Biogen buyout option, Rodin preps for an early-stage shot at Alzheimer’s

8 years ago

Sailing past the $2B mark, Flagship sets course for $500M-plus biotech fund, unveils a new startup

8 years ago

Closing in on another mega-raise, UK biotech star Immunocore grabs $40M investment from Gates Foundation

8 years ago

FDA adds two Roche studies to its growing list of partial clinical holds in wake of Keytruda deaths

8 years ago

Top 5 biopharma trends: The long-awaited biopharma revolution in China has arrived — don’t lose out

8 years ago

Lundbeck CEO bags $20M bonus jumping ship for Teva helm

8 years ago

Want to start a fight? Step one: Offer up an estimate for what it costs to develop a new drug

8 years ago

FDA takes a pass on pegvaliase panel; Flexion terminates an old AstraZeneca pact

8 years ago

Bayer boosted as FDA OKs its PI3K drug Aliqopa for relapsed follicular lymphoma patients

8 years ago

FDA commish cheers on biosimilars as Amgen, Allergan score OK for knockoff of Roche's Avastin

8 years ago

The FDA just unveiled its new, pricier fee schedule to review new drugs

8 years ago

Kerrisdale 2-0 this week: Bavarian Nordic's cancer vaccine is a bust in PhIII

8 years ago

AstraZeneca auctions off more assets in $766M deal, reports positive data for Farxiga

8 years ago

New PhIII data in hand, Pfizer, Astellas hustle ahead in bid to expand US market for Xtandi

8 years ago

Mustang ties the knot with Fred Hutch on next-gen CAR-T for lymphoma

8 years ago

AstraZeneca and Moderna take a big, early step forward in their quest to prove mRNA works in humans

8 years ago

First page Previous page 1083 1084 108510861087 1088 1089 Next page Last page